These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25033407)

  • 1. Procalcitonin-guided therapy in severe sepsis and septic shock.
    Gu WJ; Liu JC
    Crit Care; 2014 May; 18(3):427. PubMed ID: 25033407
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin-guided therapy in severe sepsis and septic shock. Authors' response.
    Schlattmann P; Brunkhorst FM
    Crit Care; 2014 May; 18(3):427. PubMed ID: 25473656
    [No Abstract]   [Full Text] [Related]  

  • 3. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers.
    Salluh JI; Nobre V; Povoa P
    Crit Care; 2014 May; 18(3):142. PubMed ID: 25032999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration.
    Oh JS; Kim SU; Oh YM; Choe SM; Choe GH; Choe SP; Kim YM; Hong TY; Park KN
    Am J Emerg Med; 2009 Sep; 27(7):859-63. PubMed ID: 19683118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials of biomarker-guided antimicrobial therapy in sepsis: improvements in trial design require better control groups.
    Salluh JI; Póvoa P
    Crit Care Med; 2014 Feb; 42(2):e172. PubMed ID: 24434473
    [No Abstract]   [Full Text] [Related]  

  • 8. Procalcitonin or C-reactive protein: that is the question?
    Corona A; De Iaco M
    Crit Care Med; 2014 Apr; 42(4):e310-1. PubMed ID: 24633120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a biomarker for toxic shock syndrome.
    Kato M; Kaneko S; Takagaki K; Kohayagawa Y; Watanabe T; Yoshida Y; Yamamoto O
    Acta Derm Venereol; 2010 Jul; 90(4):441-3. PubMed ID: 20574626
    [No Abstract]   [Full Text] [Related]  

  • 12. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
    Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
    Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The authors reply.
    Nobre V; Oliveira CF; Oliveira CR
    Crit Care Med; 2014 Apr; 42(4):e311-2. PubMed ID: 24633121
    [No Abstract]   [Full Text] [Related]  

  • 14. The authors reply.
    Nobre V; Oliveira CF; de Oliveira CR
    Crit Care Med; 2014 Feb; 42(2):e173. PubMed ID: 24434474
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
    Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
    Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M
    BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of progressive shock and highly elevated procalcitonin level.
    Schumm J; Pfeifer R; Ferrari M; Kuethe F; Figulla HR
    Am J Crit Care; 2010 Jan; 19(1):96-3. PubMed ID: 19304564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin Is Useful for Antibiotic Deescalation in Sepsis and Septic Shock: Beware of Some Confounders!
    Honore PM; Redant S; Kaefer K; Barreto Gutierrez L; Kugener L; Attou R; Gallerani A; De Bels D
    Crit Care Med; 2021 Jun; 49(6):e659. PubMed ID: 34011841
    [No Abstract]   [Full Text] [Related]  

  • 19. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
    Albrich WC; Harbarth S
    Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chipping away at unnecessary antibiotic use in the ICU, one day and one study at a time.
    Fraimow HS
    Crit Care Med; 2013 Oct; 41(10):2447-8. PubMed ID: 24060778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.